Promethera Biosciences
Biotechnology; Pharmaceutical; Therapeutics
Promethera Biosciences has raised €47M across 2 funding rounds from 7 investors, most recently a Series D+ round in Oct 2019. Based in Mont-Saint-Guibert, Belgium; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€47M
€47,200,000
Funding rounds
2
Investors
7
distinct backers
Active since
2019-04
latest 2019-10
Funding by year
EUR raised per yearPromethera Biosciences — funding by year — interactive chart.
Data table
| Promethera Biosciences — funding by year | |
|---|---|
| 2019 | €47M |
Signals
High confidenceRaise-next likelihood8
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (17y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series D+ | €7.5M | Sony Innovation Fund | View deal → |
| 2019-04-01 | Series D+ | €40M | Ci:z Investment LLP,ITOCHU Corporation,Korea Investment Partners,Mirae Asset Venture Investment,Mitsui & Co,Shinsei Capital Partners | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData